Healthcare Business News
Allan Oberman CEO Teva Americas Generics

Oberman named CEO of Teva Americas Generics

By Jaimy Lee
Posted: November 5, 2012 - 2:45 pm ET

Teva Pharmaceutical Industries, a Jerusalem-based generic-drug manufacturer, named Allan Oberman president and CEO of the company's Teva Americas Generics.

Oberman, who most recently served as Teva's senior vice president of North America Generic Pharmaceuticals, will continue to lead the North America generics business, as well as the Latin American business, according to a news release. His age was not immediately available.

Advertisement | View Media Kit


He replaces William Marth, who is serving as a senior adviser to Teva President and CEO Dr. Jeremy Levin until he retires at the end of next year. Levin was named president and CEO of Teva early this year.

What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...



Switch to the new Modern Healthcare Daily News app

For the best experience of on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.